Table 1.
Demographic and clinical characterstics of our study population
| Characteristic | SARS-CoV-2+ patients |
|---|---|
| Sex, no. of patients/total patients (%) | |
| Male | 84/130 (64.6%) |
| Female | 46/130 (35.4%) |
| Age range, no. of patients/total patients (%) | |
| 0–25 | 0/130 (0%) |
| 26–50 | 29/130 (22.3%) |
| 51–75 | 65/130 (50%) |
| > 75 | 36/130 (27.7%) |
| Symptoms, no. of patients/total patients (%) | |
| Fever | 113/130 (86.9%) |
| Coughing | 67/130 (51.5%) |
| Dyspnea | 56/130 (43.1%) |
| Diarrhea | 12/130 (9.2%) |
| Headache | 4/130 (3.1%) |
| Clinical and laboratory findings, no. of patients/total patients (%) | |
| Increased CRP level | 113/130 (86.9%) |
| Increased D-dimer level | 114/130 (87.7%) |
| Leukopenia | 39/130 (30%) |
| Decreased lymphocyte count | 80/130 (61.5%) |
| Decreased O2 saturation | 53/130 (40.1%) |
| Decreased PaO2/FiO2 ratio | 86/130 (66.2%) |
| Comorbidities, no. of patients | |
| Hypertension | 42 |
| Obesity | 17 |
| Diabetes | 15 |
| Chronic obstructive pulmonary disease | 9 |
| Neoplasm | 8 |
| Chronic kidney disease | 4 |